How AAV-PHP.S Is Revolutionizing Neuroscience
Imagine trying to understand a city's communication network without being able to see the individual wires running beneath the streets or track where they lead. For decades, this has been the challenge facing neuroscientists studying the cranial sensory ganglia—clusters of nerve cells that serve as critical waystations for information traveling between our head, face, and internal organs and our brain.
These neurons help us experience the rich tapestry of taste, feel the gentle brush of a breeze against our skin, and sense the internal state of our bodies.
Cranial sensory ganglia are like busy switchboards located throughout the head and neck, each responsible for relaying different types of sensory information 1 3 .
Carries facial sensations (cranial nerve V)
Handles taste from the front of the tongue (VII)
Manages taste from the back of the tongue and throat (IX)
Conveys visceral sensations from internal organs (X)
Unlike most neurons in the brain, cranial ganglion neurons are pseudounipolar—meaning they have a single extension that splits into two branches: one traveling to peripheral tissues and the other connecting to the brainstem 1 .
The story of AAV-PHP.S begins with the broader quest to improve gene delivery to the nervous system. Adeno-associated viruses (AAVs) have long been workhorses in neuroscience research and gene therapy because of their safety profile and ability to deliver genetic material to cells without causing disease 4 .
In a landmark 2022 study published in eNeuro, researchers from the University of Miami Miller School of Medicine systematically explored the potential of AAV-PHP.S for targeting cranial sensory ganglia 1 3 .
For the first time, researchers could efficiently and non-invasively label neurons across multiple cranial ganglia:
| Cranial Ganglion | Associated Nerve | Transduction Efficiency |
|---|---|---|
| Trigeminal Ganglion | V (Trigeminal) | High |
| Geniculate Ganglion | VII (Facial) | ~66% of neurons |
| Petrosal Ganglion | IX (Glossopharyngeal) | High |
| Nodose Ganglion | X (Vagus) | High |
| Tool/Reagent | Function | Examples/Specifications |
|---|---|---|
| AAV-PHP.S Capsid | Engineered viral shell that targets peripheral neurons | Derived from AAV9 with modified surface properties 4 |
| Fluorescent Reporters | Visualize transduced neurons and their projections | GFP, mScarlet, others 1 3 |
| Calcium Indicators | Monitor neural activity in real-time | GCaMP6s, other GCaMP variants 1 3 |
| Cre-Dependent Constructs | Restrict expression to specific cell types | Flexed GFP, Flexed GCaMP; require Cre recombinase 1 3 |
| Promoters | Control timing and pattern of transgene expression | CAG (strong, ubiquitous), cell-type specific promoters 1 |
| Cre Mouse Lines | Provide genetic access to specific neuronal populations | Mafb-2A-mCherry-2A-Cre, Penk-IRES2-Cre, others 1 3 |
AAV-PHP.S offers a new way to study headache disorders like migraine and trigeminal neuralgia, which involve the very ganglia this tool can access 2 .
The specific targeting capabilities of AAV-PHP.S could be harnessed to develop treatments for conditions that involve cranial sensory pathways while minimizing effects on other tissues .
The development of AAV-PHP.S-mediated gene delivery to cranial sensory ganglia represents more than just a technical advance—it's a fundamental shift in how we can explore the intricate sensory networks that connect us to our world.
As researchers continue to refine this tool and combine it with other cutting-edge technologies like CRISPR-based gene editing and advanced microscopy, we can expect ever deeper insights into the sensory experiences that define our daily lives.